Validation of hFcRn Transgenic Mice as Powerful Models to Screen Innovative Fc-Engineered Monoclonal and Multi Specific Antibodies

Presented by Delphine Valente, Ph.D., Head of Pharmacokinetics, Modeling and Simulation, DMPK France, Sanofi